IDEAYA Biosciences, Inc. IDYA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -14.3%-3.4pp | -10.9%+3.2pp | -14.1%+20.9pp | -35.1%-3.7pp | -31.3%+1.3pp | |
| Return on assets | -13.1%-3.0pp | -10.2%+3.1pp | -13.3%+19.7pp | -32.9%-3.2pp | -29.8%+1.2pp | |
| Return on invested capital | -21.2%-4.7pp | -16.5%+9.3pp | -25.8%+21.6pp | -47.4%-6.2pp | -41.2%+3.6pp | |
| Liquidity | ||||||
| Current ratio | 10.7×-0.6× | 11.3×-1.1× | 12.4×+0.1× | 12.4×-1.5× | 13.9×-1.0× | |
| Quick ratio | 10.7×-0.6× | 11.3×-1.1× | 12.4×+0.1× | 12.4×-1.5× | 13.9×-1.0× | |
| Cash ratio | 2.4×+0.5× | 1.9×-2.7× | 4.6×+2.6× | 2.1×-0.5× | 2.6×+0.7× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $10.57-8.6% | $11.56-5.1% | $12.18+12.2% | $10.85-6.4% | $11.59-10.6% | |
| Valuation | ||||||
| Market capitalization | $2.93B-3.5% | $3.03B+27.1% | $2.38B+25.0% | $1.91B+33.0% | $1.43B-35.4% | |
| Enterprise value | $2.8B-5.0% | $2.95B+39.4% | $2.11B+16.1% | $1.82B+36.8% | $1.33B-38.3% | |
| Price / book | 3.1×+0.2× | 3×+0.8× | 2.2×+0.2× | 2×+0.6× | 1.4×-0.7× | |
| Free cash flow yield | -3%-0.6pp | -2.4%+2.0pp | -4.4%+11.2pp | -15.6%+3.1pp | -18.7%-7.4pp | |
| Earnings yield | -4.8%-1.0pp | -3.8%+3.0pp | -6.7%+10.7pp | -17.4%+4.0pp | -21.4%-9.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do IDEAYA Biosciences, Inc.'s ratios come from?
- Every ratio is computed from IDEAYA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
